These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28042775)

  • 21. MHP-1 inhibits cancer metastasis and restores topotecan sensitivity via regulating epithelial-mesenchymal transition and TGF-β signaling in human breast cancer cells.
    Lin S; Lyu X; Yu J; Sun L; Du D; Lai Y; Li H; Wang Y; Zhang L; Yin H; Yuan S
    Phytomedicine; 2016 Sep; 23(10):1053-63. PubMed ID: 27444351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
    Sun XD; Liu XE; Huang DS
    Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moscatilin Reverses EMT Progression and its Resulting Enhanced Invasion and Migration by Affecting the TGF-β Signaling Pathway in Bladder Cancer.
    Li Z; Yang J; Chen L; Chen P; Liu C; Long X; Chen B; Long J
    Anticancer Agents Med Chem; 2024; 24(14):1074-1084. PubMed ID: 38808719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
    Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
    Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
    Lee J; Hahm ER; Marcus AI; Singh SV
    Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelial to mesenchymal transition is associated with rapamycin resistance.
    Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
    Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The natural compound codonolactone attenuates TGF-β1-mediated epithelial-to-mesenchymal transition and motility of breast cancer cells.
    Fu J; Ke X; Tan S; Liu T; Wang S; Ma J; Lu H
    Oncol Rep; 2016 Jan; 35(1):117-26. PubMed ID: 26549400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antrodin C inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via suppression of Smad2/3 and β-catenin signaling pathways.
    Kumar KJ; Vani MG; Chueh PJ; Mau JL; Wang SY
    PLoS One; 2015; 10(2):e0117111. PubMed ID: 25658913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
    Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
    Jin L; Chen J; Li L; Li C; Chen C; Li S
    Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of invasion and epithelial-mesenchymal transition of human breast cancer cells by hydrogen sulfide through decreased phospho-p38 expression.
    Lv M; Li Y; Ji MH; Zhuang M; Tang JH
    Mol Med Rep; 2014 Jul; 10(1):341-6. PubMed ID: 24756435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer.
    Wang Y; Yao B; Wang Y; Zhang M; Fu S; Gao H; Peng R; Zhang L; Tang J
    Int J Mol Med; 2014 Jun; 33(6):1514-22. PubMed ID: 24676803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
    Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS
    Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin modulates oncogenic expression of HOTAIR gene via promoter methylation and reverses epithelial-mesenchymal transition in MDA-MB-231 cells.
    Golshan M; Khaleghi S; Shafiee SM; Valaee S; Ghanei Z; Jamshidizad A; Dashtizad M; Shamsara M
    J Cell Biochem; 2021 Apr; 122(3-4):385-393. PubMed ID: 33164274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Combination Therapy with Chemical Drugs and Megavoltage X-ray Exposure on Breast Cancer Stem Cells' Viability and Proliferation of MCF-7 and MDA-MB-231 Cell Lines.
    Banisharif Dehkordi F; Ghatrehsamani M; Abdolvand M; Soltani A; Masoumi SH
    Curr Pharm Des; 2024; 30(17):1341-1353. PubMed ID: 38676476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
    Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
    Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner.
    Valaee S; Yaghoobi MM; Shamsara M
    PLoS One; 2017; 12(3):e0174486. PubMed ID: 28334027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuromedin B receptor antagonism inhibits migration, invasion, and epithelial-mesenchymal transition of breast cancer cells.
    Park HJ; Kim MK; Choi KS; Jeong JW; Bae SK; Kim HJ; Bae MK
    Int J Oncol; 2016 Sep; 49(3):934-42. PubMed ID: 27571778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.